![AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use | Fierce Pharma AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/FDAONCO.jpg?VersionId=pWL1xbTIYP6uthXSK3wokixqXE3XKM1T)
AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use | Fierce Pharma
![William Feldman on X: "Obligatory mind-bending welcome ad at ATS. Airsupra, approved in 2023, will not face generic competition for years. Many patients will be unable to afford it. Its constituent components: - William Feldman on X: "Obligatory mind-bending welcome ad at ATS. Airsupra, approved in 2023, will not face generic competition for years. Many patients will be unable to afford it. Its constituent components: -](https://pbs.twimg.com/media/Fw58WjiWAAEhIbq.jpg:large)
William Feldman on X: "Obligatory mind-bending welcome ad at ATS. Airsupra, approved in 2023, will not face generic competition for years. Many patients will be unable to afford it. Its constituent components: -
![AstraZeneca's Airsupra approved in the US for asthma - Nordic Life Science – the leading Nordic life science news service AstraZeneca's Airsupra approved in the US for asthma - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2023/01/AZ1583_Biologics_in_the_treatment_of_asthma-e1673456524739.jpg)